El Hindi K, Brachtendorf S, Hartel JC, Renné C, Birod K, Schilling K, Labocha S, Thomas D, Ferreirós N, Hahnefeld L, Dorochow E, Del Turco D, Deller T, Scholich K, Fuhrmann DC, Weigert A, Brüne B, Geisslinger G, Wittig I, Link KH, and Grösch S. Hypoxia induced deregulation of sphingolipids in colon cancer is a prognostic marker for patient outcome. Biochim Biophys Acta Mol Basis Dis 2024 Jan;1870(1):166906. doi: 10.1016/j.bbadis.2023.166906
Hernandez-Olmos V, Heering J, Marinescu B, Schermeng T, Ivanov V, Moroz Y, Nevermann, S, Mathes M, Ehrler J, Alnouri WM, Wolf M, Haydo A, Schmachtel T, Zaliani A, Höfner G, Kaiser, A, Schubert-Zsilavecz, M, Beck-Sickinger A, Offermanns S, Gribbon, P, Rieger M, Merk, D, Sisignano M, Steinhilber, D, and Proschak . Development of a potent and selective G2A (GPR132) agonist. J Med Chem 2024 (accepted)
Ri K, Weng TH, Claveras Cabezudo A, Jösting W, Zhang Y, Bazzone A, Leong NCP, Welsch S, Doty RT, Gursu G, Lim TJY, Schmidt SL, Abkowitz JL, Hummer G, Wu D, Nguyen LN, and Safarian S. Molecular mechanism of choline and ethanolamine transport in humans. Nature 2024 Jun;630(8016):501-508
Sendetski M, Wedel S, Furutani K, Hahnefeld L, Carlo Angioni C, Heering J, Zimmer B, Pierre S, Banica AM, Scholich K, Tunaru S, Geisslinger G, Ji RR, and Sisignano M. Oleic acid released by sensory neurons inhibits TRPV1-mediated thermal hypersensitivity via GPR40. iScience 2024 (accepted)